General Information of Drug (ID: DMN4H8N)

Drug Name
KAF156
Indication
Disease Entry ICD 11 Status REF
Malaria 1F40-1F45 Phase 2 [1]
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C22H23F2N5O
Canonical SMILES
CC1(C2=NC(=C(N2CCN1C(=O)CN)NC3=CC=C(C=C3)F)C4=CC=C(C=C4)F)C
InChI
1S/C22H23F2N5O/c1-22(2)21-27-19(14-3-5-15(23)6-4-14)20(26-17-9-7-16(24)8-10-17)28(21)11-12-29(22)18(30)13-25/h3-10,26H,11-13,25H2,1-2H3
InChIKey
BUPRVECGWBHCQV-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
49856296
CAS Number
1261113-96-5
TTD ID
D03QHC
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

References

1 ClinicalTrials.gov (NCT01753323) Efficacy, Safety, Tolerability and Pharmacokinetics of KAF156 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection. U.S. National Institutes of Health.